Worth reading
57In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
3328000
YenWording
Definitive
How definitive the wording is.Details of issuance or disposal
Series 1 and Series 2 warrants issued through a third-party allotment using treasury shares (fixed exercise price)
Intended allottee
CVI Investments, Inc.: 2,000 Series 1 warrants and 2,000 Series 2 warrants
Total issue value
¥3,328,000
Amount of funds to be raised
¥903,328,000 (estimated net proceeds: ¥868,988,000)
Estimated issuance expenses
¥34,340,000 (amount stated as calculated from the difference from the estimated net proceeds)
Terms of the stock acquisition rights
Exercise price
¥2,000 for Series 1 warrants and ¥2,500 for Series 2 warrants. Both are fixed, with no adjustments during the exercise period.
Exercise period
From 2 November 2026 to 1 November 2032
Number of Stock Acquisition Rights
Total issuance: 4,000 warrants (2,000 Series 1 and 2,000 Series 2); number of unexercised warrants remaining: Not disclosed
Payment date
30 October 2026
| Item | Details |
|---|---|
| Type of issuance or disposal | Series 1 and Series 2 warrants issued through a third-party allotment using treasury shares (fixed exercise price) |
| Issue price and disposal price | ¥1,077 per Series 1 warrant and ¥587 per Series 2 warrant |
| Total issue value | ¥3,328,000 |
| Amount of funds to be raised | ¥903,328,000 (estimated net proceeds: ¥868,988,000) |
| Estimated issuance expenses | ¥34,340,000 (amount stated as calculated from the difference from the estimated net proceeds) |
| Payment date | 30 October 2026 |
| Intended allottee | CVI Investments, Inc.: 2,000 Series 1 warrants and 2,000 Series 2 warrants |
| Exercise price | ¥2,000 for Series 1 warrants and ¥2,500 for Series 2 warrants. Both are fixed, with no adjustments during the exercise period. |
| Exercise period | From 2 November 2026 to 1 November 2032 |
| Number of Stock Acquisition Rights | Total issuance: 4,000 warrants (2,000 Series 1 and 2,000 Series 2); number of unexercised warrants remaining: Not disclosed |
Items this document does not state (18)
Number of shares to be issued or disposed ofSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because, based on the issuance resolution dated 14 October 2026, an agreement for subscription for the entire issue was entered into with the allottees and payment of the issue price for these warrants was completed.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.